Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

254.000
-49.200-16.23%
Volume:281.40K
Turnover:75.97M
Market Cap:22.58B
PE:-302.73
High:311.200
Open:302.000
Low:241.000
Close:303.200
52wk High:765.500
52wk Low:178.000
Shares:88.88M
HK Float Shares:88.88M
Volume Ratio:3.36
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.839
ROE:-39.50%
ROA:-23.53%
PB:24.94
PE(LYR):-302.73
PS:105.44

Loading ...

Hangzhou Diagens Proposes Bylaw Amendments Expanding Business Scope into AI and Data Services

Reuters
·
Jul 07

Diagens Schedules 2026 First EGM for 23 July to Approve Business Scope Adjustment and Articles Amendment

Bulletin Express
·
Jul 07

Diagens Proposes Business Scope Expansion, Seeks Shareholder Nod at 23 July EGM

Bulletin Express
·
Jul 07

Hangzhou Diagens Biotechnology Announces Extraordinary General Meeting

Reuters
·
Jul 07

DIAGENS-B Surges Over 9% to Record High as iMedLoop Platform Establishes Comprehensive Closed-Loop Foundation, Reinforcing Core Medical AI Competitive Logic

Stock News
·
Jul 07

Diagnostic Imaging AI Firm DIAGENS-B Surges Over 13% on Launch of iMedLoop Global Medical Imaging Data Platform

Stock News
·
Jul 06

DIAGENS-B (02526) Builds iMedLoop as a Productivity Foundation, Unlocking Platform-Level Valuation Premium for Medical AI

Stock News
·
Jul 06

DIAGENS-B Unveils iMedLoop, Paving the Way for Industrial-Scale AI in Medical Imaging

Stock News
·
Jul 05

Diagens Biotechnology Sets Book Closure Window Ahead of 23 July 2026 EGM

Bulletin Express
·
Jul 03

Hangzhou Diagens Biotechnology Announces Extraordinary General Meeting

Reuters
·
Jul 03

Hangzhou Diagens Biotech Shareholders Approved 2025 Annual Report at AGM

Reuters
·
Jun 26

Hangzhou Diagens Biotechnology announces annual general meeting

Reuters
·
Jun 04

Stock Track | DIAGENS-B Soars 22.29% in Morning Session After Securing World-First Medical AI Certification

Stock Track
·
May 26

DIAGENS-B (02526) Surges Over 22% to New High as Core AI Product Secures Landmark Medical Imaging Certification

Stock News
·
May 26

World's First Medical Imaging AI Secures Top-Level Regulatory Approval: DIAGENS-B's AI AutoVision® Strengthens Technological Moat

Stock News
·
May 22

Diagens Biotechnology's Chromosome Analysis Device Gets Registration Certificate in China

MT Newswires Live
·
May 22

DIAGENS-B (02526) Secures NMPA Class III Medical Device Registration for AI AutoVision®

Stock News
·
May 22

Hangzhou Diagens Biotechnology Co Ltd - AI Autovision Receives Class Iii Medical Device Registration Certificate in China

THOMSON REUTERS
·
May 22

Registration Open for "Zhihui Financial 2026 Summer Roadshow Conference"

Stock News
·
May 18

Stock Track | DIAGENS-B Soars 9.34% Intraday on Stellar 2025 Results and 331.7% Surge in Tech Licensing Revenue

Stock Track
·
May 13